Biotech Launch Pad Profile
Biotech Launch Pad

@RiceLaunchPad

Followers
77
Following
132
Media
0
Statuses
92

https://t.co/wYWVg9iMdW

Joined September 2023
Don't wanna be here? Send us removal request.
@RiceEngineering
Rice Engineering and Computing
17 days
Rice and the @RiceLaunchPad recently hosted the second ARPA-H Biohybrid Devices Summit, showcasing the future of implantable biohybrid devices and highlighting Houston’s momentum as a national hub for the future of biotechnology. https://t.co/ckTEDqNLt3
0
4
6
@veiseho
Omid Veiseh
24 days
Thank you @creinhartking! Appreciate your support!!
@creinhartking
Cynthia Reinhart-King
24 days
Rice is celebrating faculty who have won highly prestigious awards in the past year including BioE’s own Omid Veiseh! Congrats Omid! @veiseho @Rice_BIOE
0
2
25
@ARPA_HDirector
ARPA-H
1 month
.@ARPA_H is focused on biohybrid technologies poised to transform care for diabetes, cancer, neurological illnesses, cardiac disorders and more. I look forward to kicking off the Biohybrid Devices meeting later this week at @RiceUniversity. See you in Houston!
1
5
17
@veiseho
Omid Veiseh
1 month
Houston’s ascent as biotechnology hub in focus as BIO CEO meets with ⁦@RiceUniversity⁩ , ⁦@RiceLaunchPad⁩ , medical research leaders | Rice News | News and Media Relations | Rice University
Tweet card summary image
news.rice.edu
Biotechnology Innovation Organization president and CEO John F. Crowley visited Rice as part of a tour highlighting regional biotech hubs across the country.
2
5
16
@veiseho
Omid Veiseh
2 months
Excited to have Carnrite Ventures join us at RBL LLC as investors and advisors to help us build transformative biotech companies in Houston!
Tweet card summary image
news.rice.edu
RBL LLC has secured a strategic investment from Carnrite Ventures that will support the development of its growing pipeline of therapeutic companies.
0
6
17
@a_nash0
Amanda Nash
2 months
It has been an incredible experience to be able to return to @RiceBIOE to start my lab and get the opportunity to recruit graduate students in the same department as my Ph.D. advisor @veiseho!!!
0
5
43
@RiceLaunchPad
Biotech Launch Pad
3 months
Congratulations to the RBL LLC team for securing an investment from Modi Ventures to build transformative biotech companies in Houston!!!
prnewswire.com
/PRNewswire/ -- RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies,...
0
3
5
@a_nash0
Amanda Nash
4 months
I am excited to announce that I joined @RiceEngineering as an Assistant Professor of Bioengineering! The Nash Lab will engineer extracellular vesicles (EVs) to modulate immune dynamics! Check out our website below. https://t.co/l96h0gDJLt
2
5
79
@veiseho
Omid Veiseh
4 months
Nash and Swingle join leadership team at Rice Biotech Launch Pad | Rice News | News and Media Relations | Rice University
news.rice.edu
The Rice Biotech Launch Pad has appointed Amanda Nash and Kelsey L. Swingle to its leadership team.
0
5
25
@veiseho
Omid Veiseh
4 months
Honored to be inducted into the ⁦⁦@AcadofInventors⁩ today! Especially fun to celebrate with good friends and fellow inductees ⁦@DJSiegwart⁩ ⁦@cgtraverso⁩ ⁦@khademh⁩! ⁦@RiceUniversity⁩ ⁦@RiceLaunchPad⁩!
14
5
83
@veiseho
Omid Veiseh
4 months
New paper alert: Strategies for the vascular patterning of engineered tissues for organ repair! Contest’s to Kevin and team! Great collaboration with jeff and Jessica ⁦@natBME
Tweet card summary image
nature.com
Nature Biomedical Engineering - This Review discusses recent advances in vascular biology, biomaterials chemistry and 3D printing techniques for vascular patterning in engineered tissues.
1
3
23
@SwingleKelsey
Kelsey Swingle
5 months
I am particularly excited for the opportunity to collaborate with organizations within the Rice community including the @Rice360 Institute for Global Health Technologies and the @RiceLaunchPad as well as the broader @TXMedCenter ecosystem in Houston. (2/n)
1
2
9
@SwingleKelsey
Kelsey Swingle
5 months
I am thrilled to announce that I am joining @Rice_BIOE as an Assistant Professor in July 2025! We will engineer therapeutics at the interface of biomaterials science, immune engineering, and reproductive medicine to address global health challenges. (1/n) https://t.co/5P3ILCtRCO
Tweet card summary image
swingle-lab.com
We engineer therapeutic technologies at the interface of biomaterials, immune engineering, and reproductive biology to address global health challenges.
15
11
130
@kortum
Rebecca Kortum
5 months
My wonderful @Rice_BIOE colleagues representing at the National Academies meeting on Cancer Engineering - The Convergence of Engineering & Health
1
4
20
@veiseho
Omid Veiseh
6 months
Excited to celebrate ovarcomers ⁦@ovarcome⁩ gala! Amazing to hear the story of 7 time Olympic gymnast Medal winner Shannon Miller! Very inspired to keep innovating new solutions for ovarian cancer patients ⁦@RiceLaunchPad⁩ ⁦@RiceUniversity
1
4
19
@veiseho
Omid Veiseh
6 months
Helix Park event marks official launch and lab opening of RBL LLC, advancing Rice’s research-to-market pipeline | Rice News | News and Media Relations | Rice University
news.rice.edu
Rice celebrated a major step in its translational research efforts May 5 with the official launch of RBL LLC. Held at the Texas Medical Center’s Helix Park, the event featured a keynote by Robert...
0
3
11
@veiseho
Omid Veiseh
6 months
What a great day celebrating the opening of our new labs ⁦@RiceLaunchPad⁩ RBL LLC! Amazing talks by Bob Langer and Bob Ruffolo! ⁦@RiceUniversity
Tweet card summary image
bizjournals.com
Rice University opens RBL LLC HQ at Texas Medical Center to incubate 3-4 biotech startups annually in its new 11,000-square-foot space.
0
7
30
@RiceUniversity
Rice University
7 months
A tiny device. A huge breakthrough. Rice researchers are changing the future of cancer treatment. https://t.co/ZUQp93Fg1r
1
10
16
@RDesRoches
Reginald DesRoches
7 months
TARGETED CANCER BREAKTHROUGH 🎯 @RiceUniversity researchers have developed a tiny implant that delivers immunotherapy directly to tumors — showing promising results against melanoma, pancreatic and colorectal cancers. This innovation could change the future of cancer treatment.
2
10
32